Halozyme Therap Drug Patent Portfolio

Halozyme Therap's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Halozyme Therap News

Halozyme and Quinn Emanuel win preliminary injunction against MSD regarding Keytruda SC - JUVE Patent

08 Dec, 2025

Halozyme secures German court order halting the distribution of Merck's Keytruda.

08 Dec, 2025

Merck faces a challenge with its new Keytruda formulation in Germany - STAT News

05 Dec, 2025

Halozyme Secures Initial Injunction Against Merck's Keytruda SC in Germany

04 Dec, 2025

See More